ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

Congress Urges CMS To Soften Proposal For Coverage Of ESAs in Oncology.

July 20, 2007

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999